OM
NGNE icon

Opaleye Management’s Neurogene NGNE Stock Holding History

Opaleye Management’s Portfolio NGNE Stock Details NGNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-28,750
Closed -$368K – 45
2022
Q3 		$368K Sell
28,750
-1,750
-6% -$35.7K 0.15% 38
2022
Q2 		$628K Sell
30,500
-9,000
-23% -$220K 0.28% 38
2022
Q1 		$1.49M Sell
39,500
-12,865
-25% -$751K 0.46% 35
2021
Q4 		$5.05M Hold
52,365
– – 1.07% 29
2021
Q3 		$7.57M Sell
52,365
-5,445
-9% -$834K 1.41% 23
2021
Q2 		$10.7M Sell
57,810
-3,440
-6% -$761K 1.77% 17
2021
Q1 		$15.1M Sell
61,250
-8,065
-12% -$2.06M 2.22% 13
2020
Q4 		$19.5M Hold
69,315
– – 2.55% 13
2020
Q3 		$16.6M Sell
69,315
-685
-1% -$166K 3.25% 7
2020
Q2 		$23.2M Hold
70,000
– – 4.69% 3
2020
Q1 		$15.9M Buy
70,000
+935
+1% +$192K 4.22% 5
2019
Q4 		$17M Buy
69,065
+19,315
+39% +$1.92M 3.34% 11
2019
Q3 		$2.84M Buy
+49,750
New +$3.04M 1.03% 34
2017
Q2 		– Sell
-4,250
Closed -$1.42M – 46
2017
Q1 		$1.42M Sell
4,250
-11,250
-73% -$3.95M 0.71% 34
2016
Q4 		$5.12M Hold
15,500
– – 3.02% 10
2016
Q3 		$4.14M Buy
15,500
+750
+5% +$151K 2.17% 18
2016
Q2 		$1.95M Buy
+14,750
New +$2.34M 1.3% 30

Other funds holding NGNE

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
LCM
Lynx1 Capital Management San Juan, Puerto Rico $633M AUM 173.22% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return

Opaleye Management's NGNE Position: Q4 2022 in Review

Opaleye Management sold out of Neurogene (NGNE) in Q4 2022, closing a stake of 28,750 shares — an estimated $368K sold.

Opaleye Management first reported a position in NGNE in Q2 2016 and held it in 17 quarters. The position peaked at $23.2M in Q2 2020. 45 funds tracked by Wall St. Rank hold NGNE as of Q4 2022.

  • Opaleye Management reported no remaining Neurogene position as of Q4 2022 after selling out during the quarter.
  • Opaleye Management sold 28,750 Neurogene shares in Q4 2022, an estimated $368K.
  • Opaleye Management first reported a position in Neurogene in Q2 2016 and held it in 17 quarters.
  • Opaleye Management's Neurogene position peaked at $23.2M in Q2 2020.
  • 45 funds tracked by Wall St. Rank held Neurogene as of Q4 2022.

Based on Opaleye Management's 13F filing for Q4 2022, filed 10 Feb 2023.